Literature DB >> 10666257

Nuclear accumulation of IE62, the varicella-zoster virus (VZV) major transcriptional regulatory protein, is inhibited by phosphorylation mediated by the VZV open reading frame 66 protein kinase.

P R Kinchington1, K Fite, S E Turse.   

Abstract

IE62, the major transcriptional activator protein encoded by varicella-zoster virus (VZV), locates to the nucleus when expressed in transfected cells. We show here that cytoplasmic forms of IE62 accumulate in transfected and VZV-infected cells as the result of the protein kinase activity associated with VZV open reading frame 66 (ORF66). Expression of the ORF66 protein kinase but not the VZV ORF47 protein kinase impaired the ability of coexpressed IE62 to transactivate promoter-reporter constructs. IE62 that was coexpressed with the ORF66 protein accumulated predominantly in the cytoplasm, whereas the normal nuclear localization of other proteins was not affected by the ORF66 protein. In cells infected with VZV, IE62 accumulated in the cytoplasm at late times of infection, whereas in cells infected with a VZV recombinant unable to express ORF66 protein (ROka66S), IE62 was completely nuclear. Point mutations introduced into the predicted serine/threonine catalytic domain and ATP binding domain of ORF66 abrogated its ability to influence IE62 nuclear localization, indicating that the protein kinase activity was required. The region of IE62 that was targeted by ORF66 was mapped to amino acids 602 to 733. IE62 peptides containing this region were specifically phosphorylated in cells coexpressing the ORF66 protein kinase and in cells infected with wild-type VZV but were not phosphorylated in cells infected with ROka66S. We conclude that the ORF66 protein kinase phosphorylates IE62 to induce its cytoplasmic accumulation, most likely by inhibiting IE62 nuclear import.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10666257      PMCID: PMC111708          DOI: 10.1128/jvi.74.5.2265-2277.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  68 in total

1.  Association of a major transcriptional regulatory protein, ICP4, of herpes simplex virus type 1 with the plasma membrane of virus-infected cells.

Authors:  F Yao; R J Courtney
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

Review 2.  Varicella-zoster virus. The Fourteenth Fleming lecture.

Authors:  A J Davison
Journal:  J Gen Virol       Date:  1991-03       Impact factor: 3.891

3.  Identification of new protein kinase-related genes in three herpesviruses, herpes simplex virus, varicella-zoster virus, and Epstein-Barr virus.

Authors:  R F Smith; T F Smith
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

Review 4.  Viral aspects of protein phosphorylation.

Authors:  D P Leader; M Katan
Journal:  J Gen Virol       Date:  1988-07       Impact factor: 3.891

5.  The herpesvirus protein kinase: a new departure in protein phosphorylation?

Authors:  D P Leader; F C Purves
Journal:  Trends Biochem Sci       Date:  1988-07       Impact factor: 13.807

6.  A herpes simplex virus type 1 recombinant with both copies of the Vmw175 coding sequences replaced by the homologous varicella-zoster virus open reading frame.

Authors:  G H Disney; R D Everett
Journal:  J Gen Virol       Date:  1990-11       Impact factor: 3.891

7.  The protein kinase encoded in the short unique region of pseudorabies virus: description of the gene and identification of its product in virions and in infected cells.

Authors:  G Zhang; R Stevens; D P Leader
Journal:  J Gen Virol       Date:  1990-08       Impact factor: 3.891

8.  Mapping of two varicella-zoster virus-encoded genes that activate the expression of viral early and late genes.

Authors:  G Inchauspe; S Nagpal; J M Ostrove
Journal:  Virology       Date:  1989-12       Impact factor: 3.616

9.  The conserved DNA-binding domains encoded by the herpes simplex virus type 1 ICP4, pseudorabies virus IE180, and varicella-zoster virus ORF62 genes recognize similar sites in the corresponding promoters.

Authors:  C L Wu; K W Wilcox
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

10.  Further definition of the substrate specificity of the alpha-herpesvirus protein kinase and comparison with protein kinases A and C.

Authors:  D P Leader; A D Deana; F Marchiori; F C Purves; L A Pinna
Journal:  Biochim Biophys Acta       Date:  1991-02-19
View more
  49 in total

1.  Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus.

Authors:  Yasuyuki Gomi; Hiroki Sunamachi; Yasuko Mori; Kazuhiro Nagaike; Michiaki Takahashi; Koichi Yamanishi
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  ORF66 protein kinase function is required for T-cell tropism of varicella-zoster virus in vivo.

Authors:  Anne Schaap-Nutt; Marvin Sommer; Xibing Che; Leigh Zerboni; Ann M Arvin
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

Review 3.  Varicella-Zoster virus pathogenesis and immunobiology: new concepts emerging from investigations with the SCIDhu mouse model.

Authors:  Chia-Chi Ku; Jaya Besser; Allison Abendroth; Charles Grose; Ann M Arvin
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

4.  Phosphorylation of the varicella-zoster virus (VZV) major transcriptional regulatory protein IE62 by the VZV open reading frame 66 protein kinase.

Authors:  Amie J Eisfeld; Stephanie E Turse; Sara A Jackson; Edwina C Lerner; Paul R Kinchington
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

5.  Varicella-zoster virus ORF47 protein kinase, which is required for replication in human T cells, and ORF66 protein kinase, which is expressed during latency, are dispensable for establishment of latency.

Authors:  Hitoshi Sato; Lesley Pesnicak; Jeffrey I Cohen
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

6.  The varicella-zoster virus (VZV) ORF9 protein interacts with the IE62 major VZV transactivator.

Authors:  Cristian Cilloniz; Wallen Jackson; Charles Grose; Donna Czechowski; John Hay; William T Ruyechan
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

7.  Varicella-zoster virus infection of human fibroblast cells activates the c-Jun N-terminal kinase pathway.

Authors:  Heidi J Zapata; Masako Nakatsugawa; Jennifer F Moffat
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

8.  BAG3, a host cochaperone, facilitates varicella-zoster virus replication.

Authors:  Christos A Kyratsous; Saul J Silverstein
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

9.  Cellular transcription factors Sp1 and Sp3 suppress varicella-zoster virus origin-dependent DNA replication.

Authors:  Mohamed I Khalil; John Hay; William T Ruyechan
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

10.  Myelin-associated glycoprotein mediates membrane fusion and entry of neurotropic herpesviruses.

Authors:  Tadahiro Suenaga; Takeshi Satoh; Pranee Somboonthum; Yasushi Kawaguchi; Yasuko Mori; Hisashi Arase
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.